Guru Fundamental Report for UNH

Validea's guru fundamental report assesses UnitedHealth Group (UNH) with a 77% score using the Martin Zweig Growth Investor model, placing it just below the 80% threshold for 'some interest.' While UNH, a large-cap health insurer, passed key metrics such as P/E ratio, current quarter earnings, and long-term EPS growth, it notably failed criteria related to consistent revenue growth relative to EPS and the earnings growth rate over the past several quarters, indicating areas where its growth profile deviates from the model's more stringent requirements for accelerating, persistent earnings.

Analysis

UnitedHealth Group (UNH) receives a 77% rating from Validea's Growth Investor model, based on the Martin Zweig strategy, placing it just below the 80% threshold that indicates initial interest. The analysis reveals a dichotomous fundamental picture. On one hand, UNH demonstrates strength in several key areas, passing criteria for its P/E ratio, current quarter earnings performance, long-term EPS growth, and earnings persistence, along with positive insider transaction signals. However, the model flags critical weaknesses that temper the growth outlook. Notably, the company fails on metrics comparing revenue growth to EPS growth, suggesting that bottom-line expansion may not be fully supported by top-line momentum. Furthermore, it fails tests for the earnings growth rate over the past several quarters and for current EPS growth relative to its historical rate, indicating a lack of the consistent, accelerating earnings profile that the Zweig model prioritizes.

Key Decisions for Investors

• Investors following strict growth or momentum strategies, like the Zweig model, should exercise caution as UNH's score and failures in earnings acceleration metrics signal it does not meet the high-conviction criteria of this approach.
• Given the positive marks on valuation (P/E ratio) and long-term growth, GARP (Growth at a Reasonable Price) investors might find the stock appealing, but should critically assess the sustainability of EPS growth if it continues to outpace revenue growth.
• Monitor future earnings reports closely for two key indicators: a re-acceleration of earnings growth over multiple quarters and an improvement in sales growth that aligns more closely with bottom-line performance, as these are the primary weaknesses identified.